Skip to main content
Caplight Logo









PrecisionPhage

PrecisionPhage

Private
JyväskyläHealthcare & Life Scienceshttps://www.precisionphage.com/

Last Round

VC Round

May 1, 2026

Total Funding Raised

$2.29M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PrecisionPhage is a biotechnology company that provides phage bioinformatics software, laboratory services, and an extensive phage library to combat antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Data as a Service, Freemium, Government Contracts

AI Layer

Application

Keywords

antimicrobial resistanceAMRbacteriophagephage therapybioinformatics softwarephage genomicsAI drug discoveryGMP softwarephage manufacturingphage librarybioinformatics SaaScontract research organizationCROphage cocktail designcomputational biologygenome annotation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PrecisionPhage Comparables

Compare PrecisionPhage with similar companies based on industry and business-model similarity.

PrecisionPhage comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PhageAI S.A.
83%
Rime Bioinformatics
82%
Medea Biopharma
69%

PrecisionPhage Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 1, 2026
SeedNov 12, 2024
GrantNov 12, 2024

Key People

Founding team and executive leadership

Matti Jalasvuori

Chief Executive Officer

Executive Team

PrecisionPhage Investors

Notable investors and investment history

PrecisionPhage investors
InvestorRounds
Nordic Science InvestmentsSeed
Unifund Jyväskylä OySeed
Business FinlandGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2026

    Completed a VC Round funding round.

  • Feb 22, 2026

    Grew 50% QoQ from 8 to 12 employees.

PrecisionPhage Filings

Explore SEC and related filing metadata, where available.

PrecisionPhage filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PrecisionPhage's valuation, stock price, and market status.

Is PrecisionPhage a public or private company?

PrecisionPhage is a private company.

What is the current stock price of PrecisionPhage?

PrecisionPhage is a private company with no public stock price. No recent secondary market data is available.

How much is PrecisionPhage worth (valuation)?

Valuation information for PrecisionPhage is not publicly available.

Can I buy PrecisionPhage stock?

PrecisionPhage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PrecisionPhage's last funding round?

PrecisionPhage's most recent funding round was VC Round on May 1, 2026.

Who are the main investors in PrecisionPhage?

Key investors in PrecisionPhage include Nordic Science Investments, Unifund Jyväskylä Oy, Business Finland.

Will PrecisionPhage IPO soon?

No public IPO plans have been announced for PrecisionPhage.

How can I track PrecisionPhage secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PrecisionPhage's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJyväskylä
Employee Range12
Year Founded2022
Last FundingMay 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?